Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir

This publication has 9 references indexed in Scilit:

• The Novel Immunosuppressive Agent Mycophenolate Mofetil Markedly Potentiates the Antiherpesvirus Activities of Acyclovir, Ganciclovir, and Penciclovir In Vitro and In Vivo
  Antimicrobial Agents and Chemotherapy, 1998
• PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION IN LIVER TRANSPLANTATION
  Transplantation, 1997
• Mycophenolate mofetil
  The Lancet, 1996
• CYTOMEGALOVIRUS PROPHYLAXIS IN SOLID ORGAN TRANSPLANT RECIPIENTS
  Transplantation, 1996
• Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients.
  Journal of the American Society of Nephrology, 1996
• Prophylaxis and Treatment of CMV Infections in Transplantation
  Published by Springer Nature ,1996
• Mechanism of Action of Mycophenolate Mofetil
  Therapeutic Drug Monitoring, 1995
• Successful Treatment of Progressive Mucocutaneous Infection Due to Acyclovirand Foscarnet-Resistant Herpes Simplex Virus with (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine (HPMPC)
  Clinical Infectious Diseases, 1994
• Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex Virus
  The Journal of Infectious Diseases, 1980